With an overwhelming vote, an FDA advisory committee recently recommended against approving Charleston Laboratories’ Hydexor, a fixed-dose combination drug containing hydrocodone (HC), acetaminophen and promethazine.
FEBRUARY 15, 2018
FEBRUARY 15, 2018
With an overwhelming vote, an FDA advisory committee recently recommended against approving Charleston Laboratories’ Hydexor, a fixed-dose combination drug containing hydrocodone (HC), acetaminophen and promethazine.